Medicare spending on CLL drugs skyrockets from $254M to $3.7B in 7 years, JAMA study finds
Medicare Part D in 2020 spent almost 15 times as much on treatments for the most common form of adult leukemia, known as chronic lymphocytic …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
